Surgery for predominant lesion in nonlocalized bronchiectasis

Area of Science:

• Pulmonary Medicine
• Thoracic Surgery
• Respiratory Diseases

Background:

• Nonlocalized bronchiectasis is common, yet surgical intervention data is limited.
• Understanding surgical outcomes is crucial for managing this condition.

Purpose of the Study:

• To evaluate the symptomatic response and safety of lobectomy for nonlocalized bronchiectasis.
• To assess the efficacy of resecting the predominant lesion in managing nonlocalized bronchiectasis.

Main Methods:

• Retrospective review of 37 patients undergoing lobectomy for nonlocalized bronchiectasis (2010-2013).
• Preoperative identification of the predominant lesion using CT scans or bronchoscopy.
• Comparison of preoperative and postoperative symptoms using paired analysis.

Main Results:

• No operative mortality; 21.6% experienced manageable postoperative complications.
• Significant reductions in acute infections (5.3 to 1.8/year) and hemoptysis (4.9 to 1.1/year).
• Sputum production decreased significantly (37.1 to 10.7 mL/day); 62.2% became asymptomatic, 27.0% improved.

Conclusions:

• Lobectomy for the predominant lesion is a safe surgical option for nonlocalized bronchiectasis.
• The procedure offers significant symptom relief and high patient satisfaction.
• Anatomic resection via lobectomy is a viable treatment for selected nonlocalized bronchiectasis patients.